EP 2041165 A2 20090401 - NOVEL APPLICATIONS FOR STAPHYLOCOCCUS AUREUS SBI PROTEIN
Title (en)
NOVEL APPLICATIONS FOR STAPHYLOCOCCUS AUREUS SBI PROTEIN
Title (de)
NEUE ANWENDUNGEN FÜR STAPHYLOCOCCUS-AUREUS-SBI-PROTEIN
Title (fr)
NOUVELLES APPLICATIONS DE LA PROTÉINE Sbi DE STAPHYLOCOCCUS AUREUS
Publication
Application
Priority
- GB 2007002022 W 20070531
- GB 0610776 A 20060531
Abstract (en)
[origin: WO2007138328A2] The invention relates to the Sbi protein of Staphylococcus aureus. It has been found that Sbi can bind to the C3 complement protein and various proteolytic fragments thereof and consequently is able to inhibit the three complement pathways (i.e. the classical pathway, the alternative pathway and the lectin pathway). The invention therefore provides methods and compositions for inhibition of the complement system and for treatment of inflammatory conditions characterised by undesirable activation of the complement pathway.
IPC 8 full level
C07K 14/31 (2006.01)
CPC (source: EP)
A61K 38/1709 (2013.01); C07K 14/31 (2013.01); C07K 14/472 (2013.01)
Citation (search report)
See references of WO 2007138328A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007138328 A2 20071206; WO 2007138328 A3 20080508; AU 2007266813 A1 20071206; CA 2653668 A1 20071206; EP 2041165 A2 20090401; GB 0610776 D0 20060712
DOCDB simple family (application)
GB 2007002022 W 20070531; AU 2007266813 A 20070531; CA 2653668 A 20070531; EP 07733038 A 20070531; GB 0610776 A 20060531